Homozygosity of the autosomal dominant alzheimer disease presenilin 1 E280A mutation

Neurology

Volumn 84, Issue 2, 2014, Pages 206-208

  Kosik, Kenneth S ^a   Muñoz, Claudia ^b   Lopez, Liliana ^b   Arcila, Mary Luz ^a   García, Gloria ^b   Madrigal, Lucía ^b   Moreno, Sonia ^b   Romenets, Silvia Ríos ^b   Lopez, Hugo ^b   Gutierrez, Madelyn ^b   Langbaum, Jessica B ^c   Cho, William ^d   Suliman, Shehnaaz ^d   Tariot, Pierre N ^c   Ho, Carole ^d   Reiman, Eric M ^c   Lopera, Francisco ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSIDAD DE ANTIOQUIA   (Colombia)

^c BANNER ALZHEIMER S INSTITUTE   (United States)

^d GENENTECH INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PRESENILIN; PRESENILIN 1; PSEN1 PROTEIN, HUMAN;

ADULT; ALZHEIMER DISEASE; AUTOSOMAL DOMINANT INHERITANCE; CHILD; CLINICAL ARTICLE; COLOMBIA; DEMENTIA; EXTENDED FAMILY; GENE MUTATION; HETEROZYGOTE; HOMOZYGOSITY; HUMAN; MENTAL DEFICIENCY; NOTE; ONSET AGE; POINT MUTATION; PRIORITY JOURNAL; SCHOOL CHILD; FEMALE; GENETICS; HOMOZYGOTE; MALE; MIDDLE AGED; MUTATION;

ADULT; ALZHEIMER DISEASE; CHILD; COLOMBIA; FEMALE; HOMOZYGOTE; HUMANS; MALE; MIDDLE AGED; MUTATION; PRESENILIN-1;

EID: 84925941618     PISSN: 00283878     EISSN: 1526632X     Source Type: Journal    
DOI: 10.1212/wnl.0000000000001130     Document Type: Note

References (7)

1. Lopera F, Ardilla A, Martínez A, et al. Clinical features of early-onset Alzheimer disease in a large kindred with an E280A presenilin-1 mutation. JAMA 1997;277: 793-799.
2. Lalli MA, Cox HC, Arcila ML, et al. Origin of the PSEN1 E280A mutation causing early-onset Alzheimer's disease. Alzheimers Dement 2014;10(5 suppl):S277-S283.
3. Reiman EM, Langbaum JB, Fleisher AS, et al. Alzheimer's prevention initiative: A plan to accelerate the evaluation of presymptomatic treatments. J Alzheimers Dis 2011;26 (suppl 3):321-329.
4. Zlotogora J. Dominance and homozygosity. Am J Med Genet 1997;68:412-416.
5. Ayutyanont N, Langbaum JB, Hendrix SB, et al. The Alzheimer's prevention initiative composite cognitive test score: sample size estimates for the evaluation of preclinical Alzheimer's disease treatments in presenilin 1 E280A mutation carriers. J Clin Psychiatry 2014;75:652-660.
6. Acosta-Baena N, Sepulveda-Falla D, Lopera-Gomez CM, et al. Pre-dementia clinical stages in presenilin 1 E280A familial early-onset Alzheimer's disease: A retrospective cohort study. Lancet Neurol 2011;10:213-220.
7. De Strooper B. Loss-of-function presenilin mutations in Alzheimer disease: Talking point on the role of presenilin mutations in Alzheimer disease. EMBO Rep 2007;8: 141-146.